Concepedia

C. V. Damaraju

CV

33

Publications

2.7K

Citations

22

H-Index

1992

Active since

Affiliations

Janssen (United States)(Current)

Janssen Scientific Affairs (United States)

Massachusetts General Hospital

Ortho Clinical Diagnostics (United States)

Janssen (Belgium)

C. V. Damaraju is an author at Janssen (United States) specializing in medicine, anesthesiology, and health sciences.

ORCID

Top concepts

Publications per year

1992–2023

33

Publications

33

Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial

Timo Erkinjuntti, Alexander Kurz, Serge Gauthier et al. · The Lancet · 2002 · 759 citations

, , +11

Absence of Growth Retardation in Children With Perennial Allergic Rhinitis After One Year of Treatment With Mometasone Furoate Aqueous Nasal Spray

Eric Schenkel, David P. Skoner, Edwin A. Bronsky et al. · PEDIATRICS · 2000 · 354 citations

The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial

John A. Spertus, Mary C. Birmingham, Michael E. Nassif et al. · Nature Medicine · 2022 · 224 citations · Full text

The Cognitive Benefits of Galantamine Are Sustained for at Least 36 Months

Murray A. Raskind, Elaine R. Peskind, Luc Truyen et al. · Archives of Neurology · 2004 · 165 citations

Effect of canagliflozin on serum uric acid in patients with type 2 diabetes mellitus

Melanie J. Davies, A. Trujillo, Ujjwala Vijapurkar et al. · Diabetes Obesity and Metabolism · 2015 · 139 citations · Full text

Rows per page

1–5 of 33